Advent Life Sciences Fund III LP — Form D/A
Advent Life Sciences Fund III LP of LONDON, X0, a pooled investment fund, filed a Form D amendment with the SEC on 2019-12-06. $24.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-12-06
- Form: D/A
- Accession: 0001104659-19-070649
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Amount sold: $24.8M
- Investors: 3
- Date of first sale: 2018-12-12
- Security types: equity, fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-327448
Issuer
- Name: Advent Life Sciences Fund III LP
- CIK: 0001761089
- Entity type: Limited Partnership
- Jurisdiction: UNITED KINGDOM
- Incorporated: 2018
- Address: 158-160 NORTH GOWER STREET, LONDON, X0, NW1 2ND
- Phone: 44 20 7932 2100
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| N/A Advent Life Sciences LLP | Executive Officer | London, X0 |
| N/A ALS III Carry and Co-Invest LP | Executive Officer | London, X0 |
| N/A ALS III GP LLP | Executive Officer | London, X0 |
| Kaasim Mahmood | Executive Officer | London, X0 |
| Shahzad Malik | Executive Officer | San Diego, CA |
| Rajesh Parekh | Executive Officer | London, X0 |
| N/A Advent Life Sciences LLP | Promoter | London, X0 |
| N/A ALS III Carry and Co-Invest LP | Promoter | London, X0 |
| N/A ALS III GP LLP | Promoter | London, X0 |
| Kaaism Mahmood | Executive Officer | London, X0 |
Other filings by this issuer (1)
More